ArticleIntestinal research2017

Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study.

Haruhiko Ogata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.